JP2008515980A5 - - Google Patents

Download PDF

Info

Publication number
JP2008515980A5
JP2008515980A5 JP2007536818A JP2007536818A JP2008515980A5 JP 2008515980 A5 JP2008515980 A5 JP 2008515980A5 JP 2007536818 A JP2007536818 A JP 2007536818A JP 2007536818 A JP2007536818 A JP 2007536818A JP 2008515980 A5 JP2008515980 A5 JP 2008515980A5
Authority
JP
Japan
Prior art keywords
osamu
prostaglandins
prevention
ester
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007536818A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008515980A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/036558 external-priority patent/WO2006044405A1/en
Publication of JP2008515980A publication Critical patent/JP2008515980A/ja
Publication of JP2008515980A5 publication Critical patent/JP2008515980A5/ja
Pending legal-status Critical Current

Links

JP2007536818A 2004-10-12 2005-10-11 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物 Pending JP2008515980A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61820204P 2004-10-12 2004-10-12
PCT/US2005/036558 WO2006044405A1 (en) 2004-10-12 2005-10-11 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease

Publications (2)

Publication Number Publication Date
JP2008515980A JP2008515980A (ja) 2008-05-15
JP2008515980A5 true JP2008515980A5 (enExample) 2008-11-27

Family

ID=35677621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007536818A Pending JP2008515980A (ja) 2004-10-12 2005-10-11 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物

Country Status (16)

Country Link
US (2) US20060142348A1 (enExample)
EP (1) EP1812426B1 (enExample)
JP (1) JP2008515980A (enExample)
KR (1) KR20070085340A (enExample)
CN (1) CN101076529A (enExample)
AT (1) ATE512144T1 (enExample)
AU (1) AU2005295902A1 (enExample)
BR (1) BRPI0517417A (enExample)
CA (1) CA2583710A1 (enExample)
IL (1) IL182489A0 (enExample)
MX (1) MX2007004526A (enExample)
NO (1) NO20072269L (enExample)
NZ (1) NZ554493A (enExample)
RU (1) RU2407736C2 (enExample)
SG (1) SG156637A1 (enExample)
WO (1) WO2006044405A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
RS53599B1 (sr) 2005-05-10 2015-02-27 Intermune, Inc. Piridon derivati za modulaciju stresom aktiviranog sistema proteinskih kinaza
US20090163586A1 (en) 2007-12-20 2009-06-25 Astrazeneca Ab Bis-(Sulfonylamino) Derivatives in Therapy 205
JP5627574B2 (ja) 2008-06-03 2014-11-19 インターミューン, インコーポレイテッド 炎症性および線維性疾患を治療するための化合物および方法
FR2938538B1 (fr) * 2008-11-17 2011-08-05 Univ Nice Sophia Antipolis Procede de preparation d'acides et d'esters boroniques en presence de magnesium metallique
AU2010232729A1 (en) 2009-03-31 2011-10-20 Arqule, Inc. Substituted indolo-pyridinone compounds
JP5841361B2 (ja) * 2011-06-29 2016-01-13 壽製薬株式会社 三環性化合物及びそれを含有する医薬組成物
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CA2924843A1 (en) * 2013-09-27 2015-04-02 Allergan, Inc. Compounds and methods for skin repair
CN106459042B (zh) 2014-04-02 2019-06-28 英特穆恩公司 抗纤维化吡啶酮类
GB201810092D0 (en) 2018-06-20 2018-08-08 Ctxt Pty Ltd Compounds
GB201810581D0 (en) 2018-06-28 2018-08-15 Ctxt Pty Ltd Compounds
LT4299135T (lt) 2019-06-18 2025-09-10 Pfizer Inc. Benzizoksazolo sulfonamido dariniai

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU711592B2 (en) * 1995-04-03 1999-10-14 Novartis Ag Pyrazole derivatives and processes for the preparation thereof
ZA984040B (en) * 1997-05-15 1998-11-20 Ono Pharmaceutical Co Benzenesulfonamide compounds
IL149103A0 (en) * 1999-11-30 2002-11-10 Pfizer Prod Inc 2,4-diaminopyrimidine compounds useful as immunosuppressants
BR0211810A (pt) * 2001-08-09 2004-08-24 Ono Pharmaceutical Co Derivados ácido carboxìlico e agente farmacêutico compreendendo os mesmos como ingrediente ativo
US20060089353A1 (en) * 2003-03-06 2006-04-27 Maki Iwahashi Indole derivative compounds and drugs containing the compounds as the active ingredient
JP2007516203A (ja) * 2003-07-09 2007-06-21 バイオリポックス エービー 炎症の治療に有用なインドール類
CN1925855B (zh) * 2003-12-19 2010-06-16 普莱希科公司 开发Ret调节剂的化合物和方法

Similar Documents

Publication Publication Date Title
JP2007501251A5 (enExample)
JP2003520232A5 (enExample)
JP2008515980A5 (enExample)
JP2003503454A5 (enExample)
JP2012502037A5 (enExample)
JP2006517944A5 (enExample)
JP2009545527A5 (enExample)
JP2010528011A5 (enExample)
JP2009538898A5 (enExample)
ME02688B (me) Hinazolinoni kao inhibitori humane fosfatidilinozitol 3 - kinaze delta
JP2006503588A5 (enExample)
JP2009537554A5 (enExample)
BRPI0618211B8 (pt) composição farmacêutica contendo pregabalina para dosagem uma vez ao dia e uso do referido composto
JP2005518413A5 (enExample)
JP2010535814A5 (enExample)
JP2008505857A5 (enExample)
JP2007520565A5 (enExample)
CL2007003690A1 (es) Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas.
JP2005513006A5 (enExample)
JP2011527299A5 (enExample)
JP2008513510A5 (enExample)
JP2007536277A5 (enExample)
JP2007523135A5 (enExample)
DE602008006243D1 (de) Pharmazeutische kombination aus aliskiren und valsartan
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend